Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
|
|
Denali Therapeutics Inc. (DNLI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/25/2023 |
4
| Schuth Alexander O. (COFO and Secretary) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Sold 2,522 shares
@ $23.17, valued at
$58.4k
|
|
| 08/25/2023 |
4
| Ho Carole (Chief Medical Officer) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Sold 2,522 shares
@ $23.22, valued at
$58.6k
|
|
| 08/23/2023 |
4
| Ho Carole (Chief Medical Officer) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Sold 2,478 shares
@ $22.6, valued at
$56k
|
|
| 08/23/2023 |
4
| Schuth Alexander O. (COFO and Secretary) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Sold 2,478 shares
@ $22.59, valued at
$56k
|
|
| 08/23/2023 |
4
| Watts Ryan J. (President and CEO) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Sold 2,309 shares
@ $22.59, valued at
$52.2k
|
|
| 08/23/2023 |
4
| Krognes Steve E. (Director) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Sold 1,419 shares
@ $22.6, valued at
$32.1k
|
|
| 08/17/2023 |
4
| SATO VICKI L (Director) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Sold 1,666 shares
@ $24.3, valued at
$40.5k
|
|
| 08/16/2023 |
4
| Ho Carole (Chief Medical Officer) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Sold 2,768 shares
@ $23.79, valued at
$65.9k
|
|
| 08/16/2023 |
4
| Schuth Alexander O. (COFO and Secretary) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Sold 2,772 shares
@ $23.67, valued at
$65.6k
|
|
| 08/14/2023 |
4
| Watts Ryan J. (President and CEO) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Exercised 2,526 shares
@ $0.68, valued at
$1.7k
Sold 2,526 shares
@ $25.03, valued at
$63.2k
Exercised 2,526 options to buy
@ $0.68, valued at
$1.7k
|
|
| 08/14/2023 |
4
| Ho Carole (Chief Medical Officer) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Sold 2,857 shares
@ $24.15, valued at
$69k
|
|
| 08/14/2023 |
4
| Schuth Alexander O. (COFO and Secretary) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Sold 2,853 shares
@ $24.18, valued at
$69k
|
|
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2023 |
4
| SATO VICKI L (Director) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Sold 552 shares
@ $29.55, valued at
$16.3k
Sold 1,114 shares
@ $29.98, valued at
$33.4k
|
|
| 06/05/2023 |
4
| Thornberry Nancy (Director) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Granted 4,216 shares
@ $0
Granted 12,649 options to buy
@ $30.92, valued at
$391.1k
|
|
| 06/05/2023 |
4
| Krognes Steve E. (Director) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Granted 4,216 shares
@ $0
Granted 12,649 options to buy
@ $30.92, valued at
$391.1k
|
|
| 06/05/2023 |
4
| Tessier-Lavigne Marc (Director) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Granted 4,216 shares
@ $0
Granted 12,649 options to buy
@ $30.92, valued at
$391.1k
|
|
| 06/05/2023 |
4
| Klein Peter S (Director) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Granted 4,216 shares
@ $0
Granted 12,649 options to buy
@ $30.92, valued at
$391.1k
|
|
| 06/05/2023 |
4
| Cook Jennifer E. (Director) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Granted 4,216 shares
@ $0
Granted 12,649 options to buy
@ $30.92, valued at
$391.1k
|
|
| 06/05/2023 |
4
| Schenkein David P (Director) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Granted 4,216 shares
@ $0
Granted 12,649 options to buy
@ $30.92, valued at
$391.1k
|
|
| 06/05/2023 |
4
| FLATLEY JAY T (Director) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Granted 4,216 shares
@ $0
Granted 12,649 options to buy
@ $30.92, valued at
$391.1k
|
|
| 06/05/2023 |
4
| Harris Erik (Director) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Granted 4,216 shares
@ $0
Granted 12,649 options to buy
@ $30.92, valued at
$391.1k
|
|
| 06/05/2023 |
4
| Cole Douglas G. (Director) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Granted 4,216 shares
@ $0
Granted 12,649 options to buy
@ $30.92, valued at
$391.1k
|
|
| 06/05/2023 |
4
| SATO VICKI L (Director) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Granted 4,216 shares
@ $0
Granted 12,649 options to buy
@ $30.92, valued at
$391.1k
|
|
| 05/17/2023 |
4
| Schuth Alexander O. (COFO and Secretary) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Exercised 10,000 shares
@ $5.28, valued at
$52.8k
Sold 9,200 shares
@ $28.55, valued at
$262.7k
Sold 800 shares
@ $29.23, valued at
$23.4k
Exercised 10,000 options to buy
@ $5.28, valued at
$52.8k
|
|
| 04/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2023 |
4
| Ho Carole (Chief Medical Officer) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Sold 818 shares
@ $29.8, valued at
$24.4k
Sold 2,548 shares
@ $30.1, valued at
$76.7k
|
|
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/19/2023 |
4
| Schuth Alexander O. (COFO and Secretary) has filed a Form 4 on Denali Therapeutics Inc.|
Txns:
| Exercised 10,000 shares
@ $5.28, valued at
$52.8k
Sold 9,886 shares
@ $29.53, valued at
$291.9k
Sold 114 shares
@ $29.87, valued at
$3.4k
Exercised 10,000 options to buy
@ $5.28, valued at
$52.8k
|
|
|
|
|